Raymond James has hired experienced finance professional James Kim as managing director in the firm’s Health Care Investment Banking practice.
Based in New York City, Kim will focus on the life sciences and biotechnology sectors.
“James is a talented banker with deep expertise in the biotech sector,” said Jim Bunn, president of Raymond James Global Equities and Investment Banking. “As we continue to grow the life sciences presence across our global banking platform, our focus is on attracting top-quality talent who are adept at delivering results to clients, and we’re pleased to add James to our respected group.”
Kim joins Raymond James from Cantor Fitzgerald where he spent the past three years as managing director in the health care investment banking group. Prior to Cantor Fitzgerald, Kim served as managing director of health care investment banking at Jefferies and worked at UBS in their health care investment banking group. He has more than 16 years of experience working with and advising clients in the life sciences and biopharmaceutical sectors.
“As biotech continues to disrupt the healthcare sector and grow in importance to the overall market, our clients require and appreciate counsel from experienced professionals with access to an industry-leading distribution platform,” said Andrew Gitkin, co-head of Health Care Investment Banking. “James’ ability to understand and blend both the science and finance sides of the sector is a real differentiator to clients and we’re thrilled to have him join our team.”
